Evidence map›Paper›PMID 42268573›Full record

ArticleDiscover nano2026

Gold decorated bismuth sulfide nanorods for enhanced computed tomography imaging with in vitro and in vivo validation.

Bhavesh D Kevadiya, Rosita Primavera, Ganesh Swaminathan, Jim Zhong, Anandakumar Sarella, Rajendra Prasad, Bela Desai, Jing Wang, Kenneth S Hettie, Paolo Decuzzi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bhavesh D KevadiyaDepartment of Radiology, Interventional Radiology Innovation at Stanford (IRIS), Stanford University, Palo Alto, CA, 94304, USA.
Rosita PrimaveraDepartment of Radiology, Interventional Radiology Innovation at Stanford (IRIS), Stanford University, Palo Alto, CA, 94304, USA.
Ganesh SwaminathanDepartment of Radiology, Interventional Radiology Innovation at Stanford (IRIS), Stanford University, Palo Alto, CA, 94304, USA.
Jim ZhongDepartment of Diagnostic and Interventional Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Anandakumar SarellaNebraska Center for Materials and Nanoscience, University of Nebraska Lincoln, Lincoln, NE, 68588, USA.
Rajendra PrasadSchool of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi, 221005, U.P., India.
Bela DesaiDepartment of Radiology, Interventional Radiology Innovation at Stanford (IRIS), Stanford University, Palo Alto, CA, 94304, USA.
Jing WangDepartment of Radiology, Interventional Radiology Innovation at Stanford (IRIS), Stanford University, Palo Alto, CA, 94304, USA.
Kenneth S HettieMolecular Imaging Program at Stanford (MIPS), Department of Radiology, Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA, 94305, USA.
Paolo DecuzziDivision of Oncology, Department of Medicine, Stanford University School of Medicine, 269 Campus Drive, Stanford, CA, 94305, USA.
Avnesh S ThakorDepartment of Radiology, Interventional Radiology Innovation at Stanford (IRIS), Stanford University, Palo Alto, CA, 94304, USA. asthakor@stanford.edu.

Funding

A stem cell activated cryogel bioscaffold that restores islet bioenergetics while providing oxygen and nutrients at extravascular sites of transplantationR01DK129343 · NIDDK · STANFORD UNIVERSITY · PI Avnesh Sinh Thakor · 2022 to 2026
$2.8M
Facilitating islet implantation and engraftment following transplantation using primed umbilical cord mesenchymal stem therapies and focused ultrasoundR01DK141802 · NIDDK · STANFORD UNIVERSITY · PI Avnesh Sinh Thakor · 2025 to 2026
$1.5M
NIDDK NIH HHS R01DK129343NIDDK NIH HHS R01 DK141802
6 · The paper itself

Abstract

The development of hybrid metal nanoparticles (NPs) for use as computed tomography (CT) contrast agents is a promising area of research. Achieving optimal in vivo performance of imaging for NPs is challenging and depends on their geometry, materials properties, bioreactivity, and biocompatibility. In this study, we designed and developed a novel CT contrast agent composed of gold nanoparticles (AuNPs) coordinated on the surface of bismuth sulfide-core nanorods (Au@Bi

Indexed as

Bismuth sulfide nanorodsCT imagingGold nanoparticles

Identifiers

PMID42268573
PMCPMC13253923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.